P16.06 EARLY PERFUSION CHANGES IN PATIENTS WITH RECURRENT HIGH-GRADE GLIOMAS TREATED WITH BEVACIZUMAB: PRELIMINARY EVALUATION BY THE PARAMETRIC RESPONSE MAP DERIVED FROM DYNAMIC CONTRAST-ENHANCED MRI

OBJECTIVE: To determine whether early monitoring of the effects of bevacizumab in patients with recurrent high-grade gliomas, by the Parametric Response Map derived from Dynamic Contrast-Enhanced MRI (DCE-MRI), may be a predictor of the response to treatment assessed through conventional MRI follow-...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Vidiri, A., Marzi, S., Piludu, F., Villani, V., Antenucci, A., Terrenato, I., Fabi, A., Pace, A., Carapella, C.M.
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2014
Sujets:
Poster Presentations
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4185665/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou174.303
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires